ロード中...
Vaccine adjuvants as potential cancer immunotherapeutics
Accumulated evidence obtained from various clinical trials and animal studies suggested that cancer vaccines need better adjuvants than those that are currently licensed, which include the most commonly used alum and incomplete Freund’s adjuvant, because of either a lack of potent anti-tumor immunit...
保存先:
| 出版年: | Int Immunol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4922024/ https://ncbi.nlm.nih.gov/pubmed/27006304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/intimm/dxw015 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|